Cannabinoids inhibit motility and secretion in the intestine. They are now assigned the additional task of curbing excessive inflammation, suggesting that drugs targeting the endogenous cannabinoid system could be exploited for inflammatory bowel disease.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Loftus, E.V. Gastroenterology 126, 1504–1517 (2004).
Longobardi, T., Jacobs, P. & Bernstein, C.N. Am. J. Gastroenterol. 98, 1064–1072 (2003).
Massa, F. et al. J. Clin. Invest. 113, 1202–1209 (2004).
Cravatt, B.F. et al. Nature 384, 83–87 (1996).
Liu, J. et al. J. Biol. Chem. 278, 45034–45039 (2003).
Kathuria, S. et al. Nat. Med. 9, 76–81 (2003).
Weber, A. et al. J. Lipid Res. 45, 757–763 (2004).
Hornby, P.J. & Prouty, S.M. Br. J. Pharmacol. 141, 1335–1345 (2004).
Izzo, A.A. et al. Br. J. Pharmacol. 134, 563–570 (2001).
Izzo, A.A. et al. Gastroenterology 125, 765–774 (2003).
Palladino, M.A., Bahjat, F.R., Theodorakis, E.A. & Moldawer, L.L. Nat. Rev. Drug Discov. 2, 736–746 (2003).
Bischoff, S.C. et al. Gut 44, 643–652 (1999).
Samson, M.-T. et al. J. Immunol. 170, 4953–4962 (2003).
Fachinetti, F., Del Giudice, E., Furegato, S., Passarotto, M. & Leon, A. Glia 41, 161–168 (2003).
Croci, T., Landi, M., Galzin, A.-M. & Marini, P. Br. J. Pharmacol. 140, 115–122 (2003).
Di Filippo, C., Rossi, F., Rossi, S. & D'Amico, M. J. Leukocyte Biol. 75, 453–459 (2004).
Hugot, J.-P. et al. Nature 411, 599–603 (2001).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Kunos, G., Pacher, P. Cannabinoids cool the intestine. Nat Med 10, 678–679 (2004). https://doi.org/10.1038/nm0704-678
Issue Date:
DOI: https://doi.org/10.1038/nm0704-678
This article is cited by
-
Profiles of Patients Who Use Marijuana for Inflammatory Bowel Disease
Digestive Diseases and Sciences (2018)
-
The endogenous cannabinoid system in the gut of patients with inflammatory bowel disease
Mucosal Immunology (2011)
-
Cannabinoid CB2 receptors in the gastrointestinal tract: a regulatory system in states of inflammation
British Journal of Pharmacology (2008)
-
CEACAM1 and the regulation of mucosal inflammation
Mucosal Immunology (2008)
-
Endocannabinoids, just a gut feeling
Journal of Molecular Medicine (2007)